Overview Cyclosporine A in Cardiac Arrest Status: Completed Trial end date: 2013-03-01 Target enrollment: Participant gender: Summary The investigators hypothesised that cyclosporine A administration at the onset of cardiopulmonary resuscitation, by inhibiting the mitochondrial permeability transition pore, could prevent the post cardiac arrest syndrome and improve outcomes. Phase: Phase 3 Details Lead Sponsor: Hospices Civils de LyonTreatments: CyclosporineCyclosporins